(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Sunshine Biopharma, Inc. Executive Compensation
* In original currency USD
Loading Data
|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total Amount |
|---|---|---|---|---|---|---|---|---|
| Thursday, October 17th, 2024 | 2023 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 378,000 | 182,000 | 0 | 0 | 0 | 560,000 |
| Thursday, October 17th, 2024 | 2023 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 378,000 | 182,000 | 0 | 0 | 0 | 560,000 |
| Thursday, October 17th, 2024 | 2022 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 360,000 | 10,000 | 0 | 0 | 0 | 370,000 |
| Thursday, October 17th, 2024 | 2022 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 360,000 | 10,000 | 0 | 0 | 0 | 370,000 |
| Thursday, October 17th, 2024 | 2023 | Mr. Camille Sebaaly Chief Financial Officer | 315,000 | 380,000 | 0 | 0 | 0 | 695,000 |
| Thursday, October 17th, 2024 | 2023 | Mr. Camille Sebaaly Chief Financial Officer | 315,000 | 380,000 | 0 | 0 | 0 | 695,000 |
| Thursday, October 17th, 2024 | 2022 | Mr. Camille Sebaaly Chief Financial Officer | 300,000 | 630,000 | 0 | 0 | 0 | 930,000 |
| Thursday, October 17th, 2024 | 2022 | Mr. Camille Sebaaly Chief Financial Officer | 300,000 | 630,000 | 0 | 0 | 0 | 930,000 |
| Thursday, October 17th, 2024 | 2023 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 252,000 | 8,000 | 0 | 0 | 0 | 260,000 |
| Thursday, October 17th, 2024 | 2023 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 252,000 | 8,000 | 0 | 0 | 0 | 260,000 |
| Thursday, October 17th, 2024 | 2022 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 240,000 | 245,000 | 0 | 0 | 0 | 485,000 |
| Thursday, October 17th, 2024 | 2022 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 240,000 | 245,000 | 0 | 0 | 0 | 485,000 |
| Wednesday, October 18th, 2023 | 2022 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 240,000 | 245,000 | 0 | 0 | 0 | 485,000 |
| Wednesday, October 18th, 2023 | 2022 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 240,000 | 245,000 | 0 | 0 | 0 | 485,000 |
| Wednesday, October 18th, 2023 | 2021 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 109,927 | 0 | 306,000 | 0 | 0 | 415,927 |
| Wednesday, October 18th, 2023 | 2021 | Dr. Abderrazzak Merzouki Chief Operating Officer and Director | 109,927 | 0 | 306,000 | 0 | 0 | 415,927 |
| Wednesday, October 18th, 2023 | 2022 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 360,000 | 10,000 | 0 | 0 | 0 | 370,000 |
| Wednesday, October 18th, 2023 | 2022 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 360,000 | 10,000 | 0 | 0 | 0 | 370,000 |
| Wednesday, October 18th, 2023 | 2021 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 156,380 | 0 | 306,000 | 0 | 0 | 462,380 |
| Wednesday, October 18th, 2023 | 2021 | Dr. Steve N. Slilaty Chief Executive Officer and Director | 156,380 | 0 | 306,000 | 0 | 0 | 462,380 |
| Wednesday, October 18th, 2023 | 2022 | Camille Sebaaly Chief Financial Officer | 300,000 | 630,000 | 0 | 0 | 0 | 930,000 |
| Wednesday, October 18th, 2023 | 2022 | Camille Sebaaly Chief Financial Officer | 300,000 | 630,000 | 0 | 0 | 0 | 930,000 |
| Wednesday, October 18th, 2023 | 2021 | Camille Sebaaly Chief Financial Officer | 40,000 | 0 | 306,000 | 0 | 0 | 346,000 |
| Wednesday, October 18th, 2023 | 2021 | Camille Sebaaly Chief Financial Officer | 40,000 | 0 | 306,000 | 0 | 0 | 346,000 |
